The DNA Sequencing Wars

Yesterday, I mentioned that one of the greatest technological developments that contributed to the evolution of population genetics was the automation of DNA sequencing. I was unaware, however, that the automated DNA sequencing method that most people use was patented by a group from Caltech (including Leroy Hood) in 1998. The actual invention was conceived in the early 1980s, but a competing group claims they came up with the idea first according to this article in the NYTimes.

If Enzo Biochem, the group suing Caltech over the patent, were to win their lawsuit, companies such as Applied Biosystems (which makes many of the DNA sequencers used in genetics labs) would need to redirect their royalty payments to Enzo. I guess this could affect the price of DNA sequencing machines that employ the dye termination method, but I'm not sure what the implications for research would be. This does not have any affect on alternative sequencing strategies (such as 454), which may make traditional Sanger sequencing obsolete.

More like this

Dan Hartl just finished a two day whirlwind speaking tour at my university (three talks in under 24 hours). He discussed detecting weak selection in protein coding sequences, identifying the underlying genetic causes of phenotypic variation in yeast, and the genetics of malaria parasites. I won't…
It seems like only yesterday (okay, less than two years ago) that I learned about 454 sequencing. It's the new technology that many folks think will replace dye termination Sanger sequencing using capillary arrays (the method used to sequence the human genome and many other genomes). A new…
Chad at Uncertain Principles, one of my ScienceBlogs siblings, is requesting his co-bloggers suggest the most important experiment or discovery in their field. There are a disproportionate amount of "bio-bloggers" -- though we each have our own niche -- and he's asking us to nominate "the most…
Tomorrow morning, a three-judge panel of the Court of Appeals for the Federal Circuit will hear arguments in the appeal of Association for Molecular Pathology v. U.S. Patent and Trademark Office - better known as the Myriad gene patent case.* It has the patent and genetic blogospheres in a bit of…